Latest news and press releases from Opsona Therapeutics

News

Date	Title
13-11-2009	Opsona Therapeutics Appoints CFO & Senior Business Development Executive to Management Team
09-10-2009	Opsona Therapeutics Founder Awarded Prestigious Boyle Medal
18-05-2009	Roche Venture Fund, Enterprise Ireland Commit €3.3 m To Opsona Series B Financing
04-03-2009	OPSONA & LONZA enter into manufacturing agreement for the production of a monoclonal antibody OPN-305 developed by OPSONA Therapeutics Ltd.
22-02-2009	OPSONA, CSL Form Vaccine Adjuvant R&D Collaboration Targeting Infectious Diseases And Oncology
18-02-2009	OPSONA Therapeutics closes €18M funding
02-02-2009	Antitope Ltd & Opsona Therapeutics Ltd announce successful Composite Human Antibody project
24-11-2008	Opsona Therapeutics Appoints new VP of Research
19-05-2008	Opsona's CEO is a finalist for the 2008 Ernst & Young Entrepreneur of the Year competition.
15-05-2008	Opsona Receives Milestone Payments Under Wyeth Collaboration
21-11-2007	Opsona Therapeutics In-Licenses Novel Anti-inflammatory Molecule from Nestlé
15-03-2006	Opsona and Phylogica enter into a drug discovery collaboration
13-02-2006	Opsona Therapeutics Announces a Collaboration with Wyeth on Toll-Like Receptors
24-02-2005	Opsona completes €6.6m financing agreement
01-01-2005	Opsona Therapeutics appoints CFO & Senior Business Development Executive to Management Team